Cargando…

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside

Significant progress has been achieved over the last decades in understanding the biology and mechanisms of tumor progression in urothelial carcinoma (UC). Although the therapeutic landscape has dramatically changed in recent years with the introduction of immune checkpoint inhibitors, advanced UC i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ungaro, Antonio, Tucci, Marcello, Audisio, Alessandro, Di Prima, Lavinia, Pisano, Chiara, Turco, Fabio, Delcuratolo, Marco Donatello, Di Maio, Massimo, Scagliotti, Giorgio Vittorio, Buttigliero, Consuelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909578/ https://www.ncbi.nlm.nih.gov/pubmed/35269424 http://dx.doi.org/10.3390/cells11050803

Ejemplares similares

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
por: Audisio, Marco, et al.
Publicado: (2022)

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond
por: Audisio, Alessandro, et al.
Publicado: (2022)

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives
por: Zichi, Clizia, et al.
Publicado: (2017)

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
por: Tucci, Marcello, et al.
Publicado: (2018)

How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
por: Turco, Fabio, et al.
Publicado: (2023)

Discrepancy between tumor response and hematologic response in a patient with thymoma and aplastic anemia treated with ciclosporin
por: Muratori, Leonardo, et al.
Publicado: (2020)

Vascular ageing: moving from bench towards bedside
por: Climie, Rachel E., et al.
Publicado: (2023)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
por: Xu, Yan
Publicado: (2019)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

Moving Microbiome Science from the Bench to the Bedside: a Physician-Scientist Perspective
por: Surana, Neeraj K.
Publicado: (2019)

Extracellular RNA in kidney disease: moving slowly but surely from bench to bedside
por: Hunter, Robert W., et al.
Publicado: (2020)

Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients—An Italian Single-Center Experience
por: Persano, Irene, et al.
Publicado: (2023)

Research advances in esophageal diseases: bench to bedside
por: di Pietro, Massimiliano, et al.
Publicado: (2013)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Inositol(s) from Bench to Bedside in Endocrinology and Gynecology
por: Unfer, Vittorio, et al.
Publicado: (2017)

Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review
por: Marandino, Laura, et al.
Publicado: (2020)

Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
por: Fiorica, Francesco, et al.
Publicado: (2022)

Retinoids in Fungal Infections: From Bench to Bedside
por: Cosio, Terenzio, et al.
Publicado: (2021)

Resveratrol in Cancer Patients: From Bench to Bedside
por: Berretta, Massimiliano, et al.
Publicado: (2020)

Corrigendum to “Inositol(s) from Bench to Bedside in Endocrinology and Gynecology”
por: Unfer, Vittorio, et al.
Publicado: (2017)

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways
por: Bungaro, Maristella, et al.
Publicado: (2020)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Sonochemotherapy: from bench to bedside
por: Lammertink, Bart H. A., et al.
Publicado: (2015)

Nutrition: From Bench to Bedside
por: Khan, Naim A., et al.
Publicado: (2016)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Pruritus: From the Bench to the Bedside
por: Reich, Adam, et al.
Publicado: (2018)

Silver linings at the bench and bedside
por: Katz, Steven C., et al.
Publicado: (2020)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)

Bench-to-bedside review: An approach to hemodynamic monitoring - Guyton at the bedside
por: Magder, Sheldon
Publicado: (2012)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

The role of cognitive activity in cognition protection: from Bedside to Bench
por: Li, Bin-Yin, et al.
Publicado: (2017)

Novel Therapeutic Targets in Metabolic Disorders: From the Bench to the Bedside
por: Illario, Maddalena, et al.
Publicado: (2014)

Cancer proteomics: from bench to bedside
por: Timms, J F
Publicado: (2008)

Bench-to-bedside review: Metabolism and nutrition
por: Casaer, Michaël P, et al.
Publicado: (2008)

Bench-to-bedside review: Permissive hypercapnia
por: O' Croinin, Donall, et al.
Publicado: (2005)

DNA sequencing: bench to bedside and beyond(†)
por: Hutchison, Clyde A.
Publicado: (2007)

The hantaviruses of Europe: from the bedside to the bench.
por: Clement, J, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_pvd8id2n4dm8h0svf270usuts9